Hepatitis C virus exploits cyclophilin A to evade PKR

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Viral replication necessitates overcoming host innate immunity.
• Host cyclophilins (Cyps) are implicated in viral evasion of antiviral responses, but mechanisms remain unclear.
• Hepatitis C virus (HCV) utilizes host factors for replication and immune evasion.

Purpose of the Study:

• To elucidate the mechanism by which HCV co-opts host cyclophilins (CypA) to evade antiviral responses.
• To investigate the role of CypA in the antagonism of protein kinase R (PKR) by HCV.
• To explore the potential of CypA inhibition as an antiviral strategy.

Main Methods:

• Investigated the interaction between HCV, CypA, and PKR.
• Utilized pharmacological inhibition of CypA.
• Assessed the activation of the interferon regulatory factor-1 (IRF1)-driven antiviral program.

Main Results:

• HCV co-opts host CypA to antagonize PKR-mediated antiviral responses.
• Pharmacological inhibition of CypA restores PKR activity, rescuing it from HCV NS5A antagonism.
• CypA inhibition activates an IRF1-dependent antiviral program, inhibiting HCV replication.

Conclusions:

• HCV employs CypA to subvert host antiviral defenses, specifically PKR.
• Inhibiting CypA represents a novel antiviral strategy by reactivating cellular immunity against HCV.
• Findings provide mechanistic insight into Cyp-virus interactions and the broad-spectrum activity of Cyp inhibitors.